Novartis Gets FDA Extension On High Blood Pressure Medicine Diovan …
RTT News - 8/10/2007 12:27:40 PM Research-based pharmaceutical company Novartis AG (NVS) on Friday said the U.S. FDA has granted pediatric exclusivity for the company’s high blood pressure medicine Diovan or valsartan that would result in additional six months …
